These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28895486)

  • 21. Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
    Pandey KK
    HIV AIDS (Auckl); 2014; 6():81-90. PubMed ID: 24876793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuing education case study quiz.
    Hosp Pharm; 2013 Jan; 48(1):57-9. PubMed ID: 24550569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors.
    Fessler D; Beach J; Keel J; Stead W
    Pain Physician; 2012; 15(6):489-93. PubMed ID: 23159966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.
    Mills AM; Cohen C; Dejesus E; Brinson C; Williams S; Yale KL; Ramanathan S; Wang MH; White K; Chuck SK; Cheng AK
    HIV Clin Trials; 2013; 14(5):216-23. PubMed ID: 24144898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cobicistat, a pharmacoenhancer for HIV treatments.
    Temesgen Z
    Drugs Today (Barc); 2013 Apr; 49(4):233-7. PubMed ID: 23616950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone.
    Hagan JB; Erickson D; Singh RJ
    Pain Med; 2010 Jul; 11(7):1132-5. PubMed ID: 20456080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.
    Olin JL; Spooner LM; Klibanov OM
    Ann Pharmacother; 2012 Dec; 46(12):1671-7. PubMed ID: 23136357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 25513635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat.
    Monge E; Colombo V; Giacomelli A
    Infez Med; 2019 Dec; 27(4):445-448. PubMed ID: 31846997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.
    Elliot ER; Theodoraki A; Jain LR; Marshall NJ; Boffito M; Baldeweg SE; Waters LJ
    Clin Med (Lond); 2016 Oct; 16(5):412-418. PubMed ID: 27697800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal Insufficiency With Voriconazole and Inhaled/Intranasal Corticosteroids: Case Report and Systematic Review.
    Duman AK; Fulco PP
    J Pharm Pract; 2017 Aug; 30(4):459-463. PubMed ID: 27147607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics, pharmacodynamics and clinical efficacy of elvitegravir + cobicistat + emtricitabine + tenofovir combination therapy for the treatment of HIV.
    Raffe S; Fisher M
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):427-35. PubMed ID: 25553805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When food can make the difference: The case of elvitegravir-based co-formulation.
    Cattaneo D; Baldelli S; Minisci D; Meraviglia P; Clementi E; Galli M; Gervasoni C
    Int J Pharm; 2016 Oct; 512(1):301-304. PubMed ID: 27592195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [

    One steroid injection in combination with HIV-medication resulted in a total adrenal insufficiency

    ].
    Rössner S; Höybye C
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29634071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
    Marzolini C; Decosterd L; Winterfeld U; Tissot F; Francini K; Buclin T; Livio F
    Br J Clin Pharmacol; 2017 Dec; 83(12):2835-2838. PubMed ID: 28512794
    [No Abstract]   [Full Text] [Related]  

  • 36. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
    Schott S; Schnauder G; Müssig K
    Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine.
    Rogatto F; Bouee S; Jeanbat V; Piontkowsky D; Aragao F; Bosse M
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19779. PubMed ID: 25397523
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Jungmann NA; Lang D; Saleh S; Van Der Mey D; Gerisch M
    Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):975-984. PubMed ID: 31619082
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
    Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
    J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute leg ischaemia in an HIV-infected patient receiving antiretroviral treatment.
    Navarro J; Curran A; Burgos J; Torrella A; Ocaña I; Falcó V; Crespo M; Ribera E
    Antivir Ther; 2017; 22(1):89-90. PubMed ID: 27546463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.